Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?

Author(s): Fatima Akdim, Sander I. van Leuven, John J. P. Kastelein, Erik S. G. Stroes

Journal Name: Current Pharmaceutical Design

Volume 13 , Issue 10 , 2007

Become EABM
Become Reviewer
Call for Editor


Acute coronary syndromes (ACS), i.e. unstable angina and myocardial infarction, are the leading causes of death in developed countries and developing countries alike. Lipid lowering intervention studies have demonstrated a 30% risk reduction in recurrent cardiovascular events and death, despite only modest improvement in angiographic stenosis. This discrepancy suggested that cholesterol lowering by statins may lead to stabilization of vulnerable plaques rather than reducing stenosis per se. The predominant effect of statins is to lower lipid levels by inhibiting cholesterol biosynthesis. Besides the lipid lowering effects, statins have also been shown to modulate the inflammatory status and improve endothelial function amongst others, commonly referred to as “pleiotropic effects”. In the present review we will discuss different determinants which lead to plaque vulnerability and subsequently we will expand on the plaque stabilizing or “pleiotropic” effects of statin treatment.

Keywords: Plaque vulnerability, pleiotropic, statins, HMG-CoA reductase inhibitors

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [1003 - 1012]
Pages: 10
DOI: 10.2174/138161207780487548
Price: $65

Article Metrics

PDF: 2